Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJETG.L Regulatory News (JETG)

  • There is currently no data for JETG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

15 Feb 2021 08:58

RNS Number : 0903P
JPMorgan European Invest Tst PLC
15 February 2021
 

 

JPMORGAN EUROPEAN INVESTMENT TRUST PLC

(the 'Company')

Board Succession

Legal Entity Identifier: 549300D8SPJFHBDGXS57

Information disclosed in accordance with Listing Rule 9.6.11

 

The Board of JPMorgan European Investment Trust plc (the "Company") is pleased to announce the appointment of Guy Walker as an independent Non-executive Director of the Company with effect from 15th February 2021. The appointment was made after a thorough selection process undertaken with the assistance of a third party independent search consultancy.

Guy Walker is currently Senior Adviser at the Investor Forum and has 30 years' investment experience in UK and continental European equities with roles including Managing Director of European Equities at UBS Asset Management and Global Head of ESG Investment at Schroders.

Guy Walker does not currently hold any shares in the Company. No further information is to be disclosed in respect of paragraphs 9.6.13 (2) - (6) of the Financial Conduct Authority's Listing Rules for Guy Walker.

Commenting on the appointment of Guy Walker, Josephine Dixon, the Company's Chairman, said:

"Guy Walker is a highly experienced and well regarded Senior Investment Executive with extensive knowledge of the European equities market. He will make an excellent addition to the Board at a time when the Company is navigating through challenging times."

In line with the Company's Board Succession plan, Stephen Russell will be standing down as a Director on the same day, 15th February 2021.

Commenting on the departure of Stephen Russell and the Board's Succession Plan, Josephine Dixon, the Company's Chairman, said:

"I and the Board offer our thanks for the valuable service that Stephen Russell has provided to the Company as Director, Senior Independent Director and Chairman of the Nomination Committee and wish him well for the future. Further announcements regarding changes to the composition of the Board are expected to be released in the forthcoming months."

 

JPMorgan Funds Limited

Company Secretary

15th February 2021

 

For further information, please contact:

Paul Winship

JPMorgan Funds Limited

020 7742 4000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPUMAPUPGURA
Date   Source Headline
21st Jul 202011:26 amRNSNet Asset Value(s)
20th Jul 202011:20 amRNSGearing Announcement
20th Jul 202010:50 amRNSNet Asset Value(s)
17th Jul 202011:14 amRNSNet Asset Value(s)
16th Jul 202011:10 amRNSNet Asset Value(s)
15th Jul 20205:08 pmRNSHolding(s) in Company
15th Jul 20204:35 pmRNSResult of AGM
15th Jul 202011:35 amRNSNet Asset Value(s)
14th Jul 20205:41 pmRNSHolding(s) in Company
14th Jul 202010:45 amRNSNet Asset Value(s)
13th Jul 20204:20 pmRNSTen Largest Investments
13th Jul 202011:35 amRNSGearing Announcement
13th Jul 202011:16 amRNSNet Asset Value(s)
10th Jul 202011:27 amRNSNet Asset Value(s)
9th Jul 202010:35 amRNSNet Asset Value(s)
8th Jul 202010:44 amRNSNet Asset Value(s)
7th Jul 202010:44 amRNSNet Asset Value(s)
6th Jul 202011:05 amRNSGearing Announcement
6th Jul 202011:02 amRNSNet Asset Value(s)
3rd Jul 202010:41 amRNSNet Asset Value(s)
2nd Jul 202010:39 amRNSNet Asset Value(s)
1st Jul 202012:16 pmRNSNet Asset Value(s)
30th Jun 20206:00 pmRNSTotal Voting Rights
30th Jun 202010:55 amRNSNet Asset Value(s)
29th Jun 202011:42 amRNSGearing Announcement
29th Jun 202011:25 amRNSNet Asset Value(s)
26th Jun 202011:14 amRNSNet Asset Value(s)
25th Jun 202011:06 amRNSNet Asset Value(s)
24th Jun 202011:40 amRNSNet Asset Value(s)
23rd Jun 20204:33 pmRNSHolding(s) in Company
23rd Jun 202011:42 amRNSNet Asset Value(s)
22nd Jun 202011:25 amRNSGearing Announcement
22nd Jun 202010:56 amRNSNet Asset Value(s)
19th Jun 202011:18 amRNSNet Asset Value(s)
18th Jun 202010:58 amRNSNet Asset Value(s)
17th Jun 202011:20 amRNSNet Asset Value(s)
16th Jun 202011:04 amRNSNet Asset Value(s)
15th Jun 20202:02 pmRNSGearing Announcement
15th Jun 202011:27 amRNSNet Asset Value(s)
15th Jun 20208:40 amRNSDividend Declaration
15th Jun 20207:27 amRNSFinal Results
12th Jun 202010:49 amRNSNet Asset Value(s)
11th Jun 202010:46 amRNSNet Asset Value(s)
10th Jun 20202:59 pmRNSTen Largest Investments
10th Jun 202010:50 amRNSNet Asset Value(s)
9th Jun 202010:43 amRNSNet Asset Value(s)
8th Jun 202012:30 pmRNSGearing Announcement
8th Jun 202011:49 amRNSNet Asset Value(s)
5th Jun 202011:08 amRNSNet Asset Value(s)
4th Jun 202010:52 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.